Risk Factors for Community-Onset Pneumonia Caused by Levofloxacin-Nonsusceptible Streptococcus pneumoniae

被引:8
|
作者
Seok, Hyeri [1 ]
Kang, Cheol-In [1 ]
Huh, Kyungmin [1 ]
Cho, Sun Young [1 ]
Ha, Young Eun [1 ]
Chung, Doo Ryeon [1 ]
Peck, Kyong Ran [1 ]
机构
[1] Sungkyunkwan Univ, Div Infect Dis, Dept Med, Samsung Med Ctr,Sch Med, 81 Irwon Ro, Seoul 06531, South Korea
关键词
S; pneumoniae; levofloxacin-nonsusceptible; community-onset pneumonia; risk factor; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; INFECTION; SUSCEPTIBILITIES; PREVALENCE; PATHOGENS; CHILDREN;
D O I
10.1089/mdr.2017.0416
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Fluoroquinolones are antibiotics commonly used in the treatment of infections caused by Streptococcus pneumoniae. However, rates of fluoroquinolone resistance are increasing with their frequent use. We designed this study to verify current fluoroquinolone resistance rates and risk factors for community-onset pneumococcal pneumonia. Methods: A retrospective case-control study was conducted in a tertiary referral hospital. The study population comprised patients admitted for pneumococcal pneumonia between January 2011 and May 2017. The case group included community-onset pneumonia caused by levofloxacin-nonsusceptible S. pneumoniae. The control group consisted of two patients with levofloxacin-susceptible S. pneumoniae who were admitted around the same time as each case. Results: A total of 198 pneumococcal pneumonia cases were identified during the study period. Twenty-five levofloxacin-resistant S. pneumoniae cases and 3 levofloxacin-intermediate S. pneumoniae cases were included in the case group (nonsusceptibility rate=14.1%). Multivariate analysis showed that healthcare-associated factors (odds ratio [OR] 4.78, 95% confidence interval [CI] 1.39-16.43, p=0.013), bronchopulmonary disease (OR 3.79, 95% CI 1.07-13.40, p=0.039), cerebrovascular disease (OR 6.08, 95% CI 1.24-29.75, p=0.026), and exposure to fluoroquinolones within the previous 3 months (OR 5.89, 95% CI 1.21-28.68, p=0.028) were associated with nonsusceptibility to levofloxacin. Conclusion: Independent risk factors for levofloxacin-nonsusceptible pneumococcal pneumonia were recent hospitalization, bronchopulmonary disease, cerebrovascular disease, and prior antibiotic use within 3 months. Careful selection of empirical antibiotics is thus needed in at-risk patients. Similarly, efforts to prevent the interpersonal spread of drug-resistant pathogens in long-term care facilities and to restrict unnecessary fluoroquinolone prescriptions are important.
引用
收藏
页码:1412 / 1416
页数:5
相关论文
共 50 条
  • [1] Therapeutic options among broad-spectrum β-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae
    Jones, RN
    Fritsche, TR
    Sader, HS
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (02) : 129 - 133
  • [2] High prevalence of multiresistance in levofloxacin-nonsusceptible Streptococcus pneumoniae isolates in Korea
    Lee, Sungkyoung
    Kim, Seong-Han
    Park, Misun
    Bae, Songmee
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2013, 76 (02) : 227 - 231
  • [3] Emergence of multidrug-resistant clones in levofloxacin-nonsusceptible Streptococcus pneumoniae isolates in Korea
    Baek, Jin Yang
    Kang, Cheol-In
    Kim, So Hyun
    Ko, Kwan Soo
    Chung, Doo Ryeon
    Peck, Kyong Ran
    Lee, Nam Yong
    Song, Jae-Hoon
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 91 (03) : 287 - 290
  • [4] Community-onset bacteraemia caused by fluoroquinolone-resistant Klebsiella pneumoniae: clinical epidemiology and risk factors
    Kang, Cheol-In
    Lee, Jeong-A
    Wi, Yu Mi
    Chung, Doo Ryeon
    Peck, Kyong Ran
    Lee, Nam Yong
    Song, Jae-Hoon
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 39 (02) : 181 - 182
  • [5] Risk factors for community-onset pneumonia caused by drug-resistant pathogens: A prospective cohort study
    Vasco Barreto, J.
    Dias, Claudia Camila
    Cardoso, Teresa
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 96 : 66 - 73
  • [6] The clinical characteristics and risk factors for necrotizing pneumonia caused by Mycoplasma pneumoniae in children
    Zheng, Baoying
    Zhao, Jing
    Cao, Ling
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [7] Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset pneumonia
    Wooten, D. A.
    Winston, L. G.
    RESPIRATORY MEDICINE, 2013, 107 (08) : 1266 - 1270
  • [8] Individualizing Risk of Multidrug-Resistant Pathogens in Community-Onset Pneumonia
    Falcone, Marco
    Russo, Alessandro
    Giannella, Maddalena
    Cangemi, Roberto
    Scarpellini, Maria Gabriella
    Bertazzoni, Giuliano
    Martinez Alarcon, Jose
    Taliani, Gloria
    Palange, Paolo
    Farcomeni, Alessio
    Vestri, Annarita
    Bouza, Emilio
    Violi, Francesco
    Venditti, Mario
    PLOS ONE, 2015, 10 (04):
  • [9] Levofloxacin for the treatment of pneumonia caused by Streptococcus pneumoniae including multidrug-resistant strains: pooled analysis
    Peterson, Janet
    Yektashenas, Behin
    Fisher, Alan C.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (03) : 559 - 568
  • [10] Failure of levofloxacin therapy in two cases of community-acquired pneumonia caused by fluoroquinolone-resistant Streptococcus pneumoniae and complicated with empyema
    Carlavilla, AB
    López-Medrano, F
    Chaves, F
    Villena, V
    Echave-Sustaeta, J
    Aguado, JM
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2005, 23 (05): : 270 - 273